Each day more uses of preimplantational genetic diagnosis (PGD) are being considered. In a recent article (The American Journal of Bioethics, 13; 29-38, 2013), the ethics of PGD are discussed when the procedure is used to prevent the birth of children with illnesses that affect sexual identity, such as congenital adrenal hyperplasia. To date, there has been little discussion on the use of PGD to reduce the prevalence of these illnesses. The authors believe that the use of PGD to prevent the birth of children with disorders that affect sexual anatomy is not morally justified, yet they feel that it is ethical for parents to use PDG to rectify sexual anatomy of their children.